Plutus Resources skip navigation

News Archive

For all regulatory news announcements including the latest results please click this link

Shareholding in Biocroi Limited
ThIPSO Ventures plc is delighted to announce an addition to its investment portfolio.
22 June 2011
Proposed Placing, Share Capital Reorganisation and Notice of General Meeting
The Board of IPSO is pleased to announce the conditional placing of 19,500,000 new IPSO shares
13 June 2011
Cambridge Meditech signs agreement with Lantor(UK)
IPSO Ventures plc, the technology commercialisation business, is pleased to announce that its wholly-owned subsidiary, Cambridge Meditech Limited, has signed an agreement with Lantor Limited
24 May 2011
New Spanish and Portuguese Alliance
Ipso Ventures and Knowledge Investors have formed a strategic alliance to assist Spanish and Portuguese universities to develop their technologies.
06 January 2011
Total Voting Rights
In accordance with the FSA's Disclosure and Transparency Rules, the Company would like to notify the market of the following:
30 April 2010
Issue of New Shares
The Company announces that it has issued 11,765 new ordinary shares to a consultant in respect of services provided to the Company.
01 April 2010
Axilica wins substantial grant
IPSO Ventures plc ("IPSO"), the creator of commercial value from technology, is pleased to announce that its investee company, Axilica Limited ("Axilica" or the "Company"), has been awarded a €495,000 grant (the "Grant") by the ENOSYS project.
09 March 2010
Polyfect enters due diligence agreement
IPSO Ventures plc ("IPSO"), the creator of commercial value from technology, is pleased to announce thatits investee company, Polyfect Solutions Limited ("Polyfect"), has entered into a technical due diligence agreement (the "Agreement") with a major US surface coatings company (the "US company").
15 February 2010
Interim management report 2009
Ipso Ventures plc (AIM: IPS) ("IPSO", the "Company" or the "Group"), the demand led technology commercialisation business, is pleased to announce its unaudited interim results for the six months to 31 October 2009.
29 January 2010
IPSol Energy first customer revenues
IPSO Ventures plc (“IPSO”), the creator of commercial value from technology, is pleased to announce that IPSol Energy Limited ("IPSol Energy" or the “Company”) has secured its first customer revenues within three months of being established.
14 January 2010
Ipso creates Photovoltaic Testing Business
IPSO Ventures plc ("IPSO"), the creator of commercial value from technology, has created its first business in the renewable energy sector, IPSol Energy Limited ("IPSol Energy")
4 November 2009
Preliminary Results 2009
Ipso Ventures plc (AIM: IPS) (“IPSO” or the “Company”), the demand led technology commercialisation business, is pleased to announce its unaudited preliminary results for the year ended 30 April 2009.
24th July 2009
Successful fundraising for Therakind
IPSO Ventures plc, the creator of commercial value from technology, is pleased to announce that its portfolio company, Therakind Limited, has successfully raised £350,000 from new investors.
3rd April 2009
Interim Results
Ipso Ventures plc, the creator of commercial value from technology, is pleased to announce its interim results for the period ended 31 October 2008.
19th January 2009
Acquisition of Cambridge Meditech
IPSO Ventures plc, the IP commercialisation specialist, is pleased to announce that, on Monday 3 November 2008, it acquired Cambridge Meditech Limited.
4th November 2008
Completion Of Phase Two Funding On Successful Customer Evaluation Of EDA Tool
IPSO Ventures plc the IP commercialisation specialist, is pleased to announce that, following the successful completion by Axilica Limited of its trial with a major electronics company, it has completed the Phase Two investment in the company.
16th October 2008
Successful Customer Evaluation Of EDA Tool
IPSO Ventures plc the IP commercialisation specialist, is pleased to announce that the electronic design automation tool, FalconML, developed by Axilica Limited has completed a successful trial by a major electronics company.
30th September 2008
Preliminary Results
Ipso Ventures plc the intellectual property commercialisation company, is pleased to announce its unaudited preliminary results for the year ended 30 April 2008
25th July 2008
Second Loughborough University spin-out
Ipso Management Limited has created and invested in its second spin-out company, Polyfect Solutions Limited, under its Framework Agreement with Loughborough University.
10th July 2007
First Loughborough University Spin Out
Ipso Management Limited has created and invested in its first spin out company, Axilica Limited, under its Framework Agreement with Loughborough University.
25th September 2007
Preliminary Results
Ipso Ventures plc the intellectual property commercialisation company, is pleased to announce its unaudited preliminary results for the year ended 30 April 2007
25th July 2007
Further investment in Intelligent Wound Care
Ipso Management Limited has made a further investment of £270,000 in its spin out company IWC Limited (IWC). IWC is developing devices to measure various physiological parameters which will allow a clinician to make an informed assessment of the functional status of tissues and organs.
5th July 2007
Therakind Investment
Ipso Management Limited has agreed to make a further investment of £300,000 in Therakind Limited a paediatric drug development business, which was spun-out from The School of Pharmacy, University of London in October 2006
15th June 2007
Placing and Subscription raising £4.5 million on AIM
IPSO has today published and AIM Admission Document making application to AIM in conjunction with a placing and subscrption to raise £4.5 million.
1st March 2007
 

Copyright © 2013 Plutus Resources PLC